Ramsay Health Care Australia has been let off the hook for using emails subpoenaed in a defamation case between two feuding surgeons at one of its hospitals, with a judge accepting that an in-house lawyer was “mortified” by her mistake and was “drowning in work” at the time.
The judge overseeing the scandal-ridden Banksia Securities class action has questioned why a solicitor on record for the case hasn’t handed over his ill-gotten fees despite professed regret for his actions and his claims to have reformed.
The NSW Court of Appeal has granted Bianca Rinehart’s bid for her billionaire mother Gina to hand over trust documents that could be used in a dispute over ownership of the $4 billion family trust.
The High Court has rejected plumbing company Repipe’s application to hear its case centred on the question of patent eligibility for computer-implemented inventions, saying the case was not an appropriate vehicle for special leave.
Bill Papas’ girlfriend Louise Agostino has hit back at Westpac’s lawsuit accusing her of involvement in the Forum Group director’s alleged $294 million fraud, denying all allegations and arguing that the bulk of the bank’s claims against her should be struck out.
The behaviour of the legal team running the Banksia Securities class action was “reprehensible” and the solicitor who allowed himself to be controlled by lawyer and funder Mark Elliott should be struck from the court’s roll of practitioners, a judge heard Tuesday.
Eleven women will give evidence of sexually inappropriate behaviour by actor Craig McLachlan in his defamation case against Rocky Horror Show co-star Christie Whelan Browne and publishers ABC and Fairfax, including one actress who worked with him on the set of Neighbours in the late 1980s.
AMP has admitted two of its units charged customers fees for no service but denied it acted unconscionably in a case brought by the corporate regulator alleging it continued to charge advice fees and life insurance premiums to customers who had died.
Pharmaceutical giant Pfizer has fired off a lawsuit against four drug companies for allegedly infringing one of its patents for biologic Enbrel by selling a biosimilar of the blockbuster arthritis drug in Australia.
The corporate regulator has taken Australian Mines to court after its managing director was allegedly caught lying at an investment conference about the value of an offtake agreement and funding for a project at its cobalt and nickel mine in Queensland.